These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis]. Zsíros J; Sólyom E Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773 [No Abstract] [Full Text] [Related]
3. Human pancreatic graft fistula exocrine suppression by oral pancreatic enzymes. Burton FR; Garvin PJ; Joshi SN Transplantation; 1989 May; 47(5):888-91. PubMed ID: 2655228 [No Abstract] [Full Text] [Related]
4. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function. Braga M; Cristallo M; De Franchis R; Mangiagalli A; Agape D; Primignani M; Di Carlo V Surg Gynecol Obstet; 1988 Dec; 167(6):485-92. PubMed ID: 3187872 [TBL] [Abstract][Full Text] [Related]
5. Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into the future. George DE; Mangos JA J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S49-57. PubMed ID: 3042940 [No Abstract] [Full Text] [Related]
6. Solubility of oral pancreatic enzyme supplement capsules in biological fluids. Robb TS; Davidson GP; Cooper DM Lancet; 1980 Sep; 2(8193):544. PubMed ID: 6105599 [No Abstract] [Full Text] [Related]
7. [Comparative clinical study of Neopanpur and Creon]. Beró T; Jávor T Orv Hetil; 1994 Jan; 135(1):7-14. PubMed ID: 8290236 [TBL] [Abstract][Full Text] [Related]
8. Dissolution of an esophageal bezoar with pancreatic enzyme extract. Gupta R; Share M; Pineau BC Gastrointest Endosc; 2001 Jul; 54(1):96-9. PubMed ID: 11427854 [No Abstract] [Full Text] [Related]
9. Pancreatic enzyme replacement therapy in post-pancreatectomy patients. Braga M; Cristallo M; De Franchis R; Mangiagalli A; Zerbi A; Agape D; Primignani M; Di Carlo V Int J Pancreatol; 1989; 5 Suppl():37-44. PubMed ID: 2702249 [TBL] [Abstract][Full Text] [Related]
10. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice. Littlewood JM Postgrad Med J; 1996 Mar; 72 Suppl 2():S56-62; discussion S59-62. PubMed ID: 8869184 [No Abstract] [Full Text] [Related]
11. Exocrine pancreatic insufficiency in a cat. Browning T Aust Vet J; 1998 Feb; 76(2):104-6. PubMed ID: 9578779 [No Abstract] [Full Text] [Related]
12. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of the gastric bezoar by endoscopy]. Degollado JR; Bojórquez JP Rev Gastroenterol Mex; 1977; 42(2):54-9. PubMed ID: 617236 [TBL] [Abstract][Full Text] [Related]
14. [Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation]. Freise J; Horstkotte H Fortschr Med; 1986 Sep; 104(33):625-8. PubMed ID: 3639835 [No Abstract] [Full Text] [Related]
15. [Case of a gastric bezoar]. Ryzhkov GF; Trautman EA Vestn Rentgenol Radiol; 1985; (2):76-7. PubMed ID: 4013070 [No Abstract] [Full Text] [Related]